Clinical Trials Logo

Stage IIB Prostate Cancer clinical trials

View clinical trials related to Stage IIB Prostate Cancer.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT02179762 Withdrawn - Clinical trials for Recurrent Prostate Cancer

Vigorous or Moderate Exercise in Enhancing Active Surveillance in Patients With Localized Prostate Cancer

EASE
Start date: August 9, 2014
Phase: N/A
Study type: Interventional

This randomized pilot clinical trial compares vigorous or moderate exercise in enhancing active surveillance in patients with prostate cancer that has not spread to nearby lymph nodes or to other parts of the body. Active surveillance involves watching the patient's condition but not giving any treatment unless test results show that the patient's condition is getting worse. Exercise may improve fitness, quality of life, brain health, and blood biomarkers in patients with prostate cancer on active surveillance. It is not yet known whether vigorous or moderate exercise works better in enhancing active surveillance in patients with localized prostate cancer.

NCT ID: NCT01859689 Withdrawn - Clinical trials for Adenocarcinoma of the Prostate

Internal Radiation Therapy in Treating Patients With Low-Risk Prostate Cancer

Start date: March 2012
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well internal radiation therapy works in treating patients with low-risk prostate cancer. Internal radiation uses radioactive material placed directly into or near a tumor to kill tumor cells.

NCT ID: NCT01555632 Withdrawn - Clinical trials for Recurrent Prostate Cancer

Atorvastatin Calcium in Preventing Metabolic Syndrome in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy

Start date: March 2012
Phase: N/A
Study type: Interventional

This randomized pilot clinical trial studies atorvastatin calcium in preventing metabolic syndrome in patients with prostate cancer receiving long-term androgen-deprivation therapy. Atorvastatin calcium may help prevent or reduce metabolic syndrome caused by long-term androgen-deprivation therapy